The Premier Virtual Differentiated iPSC Meeting - From Ideation to Implementation

Join us for the first virtual iForum™ meeting where innovators from academia, government, biotech, and pharma will detail breakthrough applications enabled by differentiated human iPSCs. Register now for this free, two-day, online event.

Dates

Wednesday, January 27th - Thursday, January 28th

Speakers

The full list of speakers, talk titles and abstracts will be announced soon. The current list of confirmed speakers includes:

  • Caroline Archer, PhD - AstraZeneca
  • Silvia Cainarca, PhD - AXXAM, S.p.A.
  • Yasunari Kanda, PhD - National Institute of Health Sciences, Japan
  • Tomohiro Kawamoto, PhD - Axcelead Drug Discovery Partners
  • Camille Nicoleau, PhD - IPSEN
  • Francesca Pistollato, PhD - European Commission, Joint Research Centre
  • Frederick Sannajust, PhD - Independent Safety Pharmacology/Toxicology Consultant, Former Executive Director of Safety and Exploratory Safety Pharmacology at MERCK Research Laboratories, West-Point, PA, USA.
  • Ilyas Singeç, MD, PhD - Director, Stem Cell Translation Laboratory, NIH Regenerative Medicine Program, National Center for Advancing Translational Sciences (NCATS)
  • Takahiro Tanaka, PhD, RPh - Axcelead Drug Discovery Partners
  • Marija Usenovic, PhD - Merck & Co
  • Alison Walker, PhD - AstraZeneca
  • More to be announced soon!

Research-focused Agenda

iForum 2021 Meeting agenda is packed with thought-provoking and visionary scientific presentations. This 2 half-day event will highlight the use of human iPSC-derived cells for disease modeling, drug discovery and predictive toxicology in the cardiac and neural fields.

Day 1

iPSC-Derived Cardiomyocytes


Time

Session

Speakers


9:00 am- 9:10 am Welcome

9:10 am - 11:10 am Cardiac Predictive Toxicology
  • Yasunari Kanda, PhD - National Institute of Health Sciences, Japan
  • Frederick Sannajust, PhD - Independent Toxicology Consultant, Former Executive Director Of Safety and Exploratory Safety Pharmacology, Merck
  • Nanion Techologies - Speaker to be Announced
  • Additional Speakers to be Announced

11:15 am - 12:10 pm Cardiac Disease Modeling and Drug Discovery
  • Caroline Archer, PhD - AstraZeneca
  • Alison Walker, PhD - AstraZeneca
  • Additional Speakers to be Announced

12:15 pm - 12:25 pm Closing Statements

 

Day 2

iPSC-Derived Neural Cells


Time

Session

Speakers


9:00 am- 9:10 am Welcome

9:10 am - 12:30 am Neural Discovery, Disease Modeling and Toxicology
  • Tomohiro Kawamoto, PhD - Axcelead Drug Discovery Partners
  • Silvia Cainarca, PhD - AXXAM, S.p.A.
  • Francesca Pistollato, PhD - European Commission, Joint Research Centre
  • Camille Nicoleau, PhD - IPSEN
  • Ilyas Singeç, MD, PhD - National Center for Advancing Translational Sciences (NCATS)
  • Takahiro Tanaka, PhD, RPh - Axcelead Drug Discovery Partners
  • Marija Usenovic, PhD - Merck & Co
  • Additional Speakers to be Announced

12:15 pm - 12:25 pm Closing Statements

Partners

AXXAM Nanion